China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People's Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers. It also provides healthcare related research and promotion services in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines; and provision of agency and healthcare related services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Central, Hong Kong.
Research context
China NT Pharma Group Company Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
China NT Pharma Group Company Limited is currently in a long term downtrend where the price is trading 6.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
China NT Pharma Group Company Limited's total revenue sank by 50.3% to $89M since the same quarter in the previous year.
Its net income has increased by 86.0% to $-83M since the same quarter in the previous year.
Finally, its free cash flow grew by 162.8% to $14M since the same quarter in the previous year.
Based on the above factors, China NT Pharma Group Company Limited gets an overall score of 3/5.